Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Segal

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
JAMA Network Open|August 9, 2023
Germline Variants Incidentally Detected via Tumor-Only Genomic Profiling of Patients With MesotheliomaOwen D Mitchell, Katie Gilliam, Daniela Del Gaudio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2017
B-Cell Lymphoma Patient-Derived Xenograft Models Enable Drug Discovery and Are a Platform for Personalized TherapyLeo Zhang, Krystle Nomie, Hui Zhang, et al.
Blood Cancer Journal|June 18, 2024
Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasmsAmandeep Kaur, Alexandra E Rojek, Emily Symes, et al.
Research Square|November 30, 2021
Severe COVID-19 infection is associated with aberrant cytokine production by infected lung epithelial cells rather than by systemic immune dysfunctionSherin J Rouhani, Jonathan A Trujillo, Athalia R Pyzer, et al.
Nature|October 9, 2024
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitorsFerdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
JAMA Network Open|August 9, 2023
Germline Variants Incidentally Detected via Tumor-Only Genomic Profiling of Patients With MesotheliomaOwen D Mitchell, Katie Gilliam, Daniela Del Gaudio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2017
B-Cell Lymphoma Patient-Derived Xenograft Models Enable Drug Discovery and Are a Platform for Personalized TherapyLeo Zhang, Krystle Nomie, Hui Zhang, et al.
Blood Cancer Journal|June 18, 2024
Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasmsAmandeep Kaur, Alexandra E Rojek, Emily Symes, et al.
Research Square|November 30, 2021
Severe COVID-19 infection is associated with aberrant cytokine production by infected lung epithelial cells rather than by systemic immune dysfunctionSherin J Rouhani, Jonathan A Trujillo, Athalia R Pyzer, et al.
Nature|October 9, 2024
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitorsFerdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, et al.
Pageof 5